Dynamic contrast-enhanced MRI for evaluation of cardiac tumors

MR first pass perfusion of benign and malignant cardiac tumours—significant differences and diagnostic accuracy

“…However, data dealing with Table 3 Mean values and standard deviation of the signal enhancement and the slope of the signal enhancement curve of all benign and malignant cardiac tumours, the myocardium and tumour tissue in relation to normal myocardium. P values indicate significant differences between malignant and benign tumours RSE and slopeRSE of tumour tissue and myocardium and tumour tissue in relation to normal myocardium cardiac tumour perfusion are rare and the clinical use of first pass contrast-enhanced MR perfusion techniques in the characterisation of cardiac tumours has still to be defined and needs further investigation [8]. Different types of cardiac perfusion techniques allow for imaging and evaluation of the tumour perfusion characteristics.…”

“…It may also be hypothesised that first pass MR perfusion imaging potentially contributes additional information in the diagnosis and differentiation of benign and malignant cardiac tumours, however few data have been published and further investigation is desirable [8].…”

CMR and MDCT in Cardiac Masses

“…Different CMR techniques at 1.5T, proposed for the evaluation of a cardiac mass, are described further on [1][2][3][4][5][6]. Cardiac gating is a prerequisite in a CMR study.…”

“…These MR techniques are used to measure myocardial perfusion [8] after gadolinium chelate injection, but can be used to assess cardiac mass perfusion [5]. These sequences are T1-weighted, have a high temporal resolution and provide images on three or four different slice levels (usually three different short axis views, and one long axis view) in one RR interval.…”